Warning! Javascript on your browser is not enabled!

We have found that Javascript is disabled on your internet browser. Many features of this site will not work without JavaScript enabled. To get the best possible experience using our website, we recommend that you enable the JavaScript in your browser.

News & Updates - Partners in Bleeding Disorders Education
  • October, 19 2022 October

    Gene Therapy for Providers CE Education | Oct 2022

    Partners in Bleeding Disorders Education is pleased to announce the release of a 3-part continuing medical education series on the use of gene therapy for hemophilia.

    Gene Therapy for Providers 101 provides basic education on hemophilia gene therapy, including the aims of gene therapy, the packaging, delivery, and activity of the replacement genes; and how the replacement genes lead to production and/or availability of normal clotting factor in persons with hemophilia. Gene Therapy for Providers 201 is a process-oriented intermediate activity that will guide HTC multidisciplinary staff and institutional stakeholders to gain knowledge on the steps necessary to prepare an institution to administer AAV-mediated gene therapy for hemophilia. Gene Therapy for Providers 301 is a process-oriented activity that will enable HTC multidisciplinary staff and hospital staff to support patients and their families as they consider hemophilia gene therapy, including education of patients and families on basic concepts in hemophilia gene therapy; administrative preparedness for providers; and short- and long-term care demands.

    These activities are intended for multidisciplinary providers at hemophilia treatment centers, including nurses, physicians, pharmacists, physical therapists, social workers, and genetic counselors providing care to persons with hemophilia A and hemophilia B.

    Complimentary continuing education credit provided for physicians, physician assistant, pharmacists, nurse practitioners, and nurses. Click on the Online Education tab above for the full accreditation information and participate in all 3 activities today!

    In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • September, 01 2022 September

    Advance Care Planning and Advance Directives | August 2022

    Partners in Bleeding Disorders Education Program is pleased to announce the release of the enduring activity Advance Care Planning and Advance Directives. This module was authored by Stephanie VanSlyke, BA, RN, HEC-C, Senior Coordinator of Ethics and Advance Care Planning, Munson Medical Center.

    This accredited continuing education activity provides education on the development of a robust Advance Care Planning (ACP) program and covers the goals, barriers, and enabling strategies to implement an ACP program with patients. The module also provides many ACP resource documents, patient decision aids, and how to facilitate these ACP conversations. The content level of this activity is intermediate.

    Advance Care Planning and Advance Directives is designed for physicians, advance practice clinicians, social workers, and nurses caring for patients with bleeding disorders. In addition, target care managers, spiritual care specialists, and other multidisciplinary providers involved in caring for patients with bleeding disorders may find this information beneficial.

    Complimentary continuing education credit provided for physicians, physician assistants, nurse practitioners, and nurses. Click the Online Education tab for complete details and to enroll in the module today!


    In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • June, 01 2022 June

    Hereditary Hemorrhagic Telangiectasia: Right Under Your Nose | June 2022

    Partners in Bleeding Disorders Education is pleased to announce the release of Hereditary Hemorrhagic Telangiectasia: Right Under Your Nose. This module was authored by Dr. Manjusha Kumar, Pediatric Hematologist and Dr. Magdalena Lewandowska, Adult Hematologist at the Indiana Hemophilia and Thrombosis Center.

    This accredited continuing education activity provides a detailed introduction to hereditary hemorrhagic telangiectasia (HHT) appropriate for an audience of multidisciplinary health care providers involved in the team-based care of patients with HHT. This overview includes information on the genetic inheritance and pathophysiology of HHT as well as the widely-used Curaçao diagnostic criteria to determine if a person has HHT, consensus screening guidelines for HHT management, and an explanation of the importance of a multidisciplinary approach to care of patients with HHT. This activity incorporates case scenarios and interactive questions to encourage active learning through application of the content.

    HHT: Right Under Your Nose is designed for physicians, physician assistants, nurse practitioners, nurses, and other multidisciplinary team members who care for patients with hereditary hemorrhagic telangiectasia.

    Complimentary continuing education credit provided for physicians, physician assistants, nurse practitioners, and nurses. Click the Online Education tab for complete details and to enroll in the module today!


    In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • June, 01 2022 June

    A School Nurse's Guide to Bleeding Disorders: Hemophilia | May 2022

    A School Nurse’s Guide to Bleeding Disorders: Hemophilia is designed for school nurses, nurse practitioners, and other school personnel who require basic knowledge and skill to effectively practice and teach in schools attended by a student with hemophilia. This involves debunking common myths that persist about hemophilia and replacing those myths with factual information concerning the etiology, inheritance, severity, and treatment of hemophilia. It includes information on identifying prevalent locations and symptoms of bleeding in hemophilia. Finally, the activity reviews strategies that may be implemented in the school setting to promote a safe and positive learning environment for the student with hemophilia.

    FREE ANCC contact hours are available.

    For more information or to view the module today, click the Online Education tab above!


    In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • March, 07 2022 March

    Understanding Hemophilia | March 2022

    Understanding Hemophilia is a 6-part online learning activity that aims to enable clinicians at U.S. Hemophilia Treatment Centers to gain knowledge and develop expertise on the pathogenesis, inheritance, symptoms, potential complications, and clinical management of hemophilia.

    This enduring activity is appropriate for nurses, nurse practitioners, physician assistants, and other clinical staff within the federally recognized U.S. HTC network who wish to develop an understanding of basic concepts of hemophilia. This activity is particularly appropriate for clinicians within their first six months of employment at an HTC.

    FREE accredited continuing education credits available for up to 2 ANCC contact hours and 2 AAPA Category 1 CME credits.

    For more information or to view the modules today, click the Online Education tab above!

    In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • January, 10 2022 January

    MASAC Pain Initiative Task Force Pain Management Guidelines for Bleeding Disorders | January 2022

    Partners in Bleeding Disorders Education is pleased to announce the release of a 4-part continuing medical education series on MASAC Pain Management Guidelines for Bleeding Disorders. This module will enable you to gain knowledge on the opioid guidance document published in early 2020 by the Medical and Scientific Advisory Council (MASAC). The MASAC Opioid guidance document was created by The Pain Initiative Task Force, a multidisciplinary committee of the National Hemophilia Foundation (NHF). This document was fashioned from the Center for Disease Control and Prevention (CDC).

    The 4-part module series is divided into the following segments based on the MASAC opioid guidance document: • Part A: Screening & Risk Assessment • Part B: Determining When to Initiate or Continue Opioids • Part C: Opioid Selection, Dosage, Duration and Other Considerations • Part D: Opioid Monitoring and Tapering or Discontinuation; as well as special considerations related to opioid pain management

    These activities are intended for multidisciplinary providers at hemophilia treatment centers, including physicians, nurse practitioners, nurses, physician assistants, social workers, physical therapists, and other members of the bleeding disorder comprehensive care team.

    The activity provides continuing education credit for physicians, nurses, social workers, and physical therapists.

    For more information or to view the modules today, click the Online Education tab above!

  • December, 27 2021 December

    Gene Therapy for Providers Education | Dec 2021

    Partners in Bleeding Disorders Education is pleased to announce the release of a 3-part continuing medical education series on the use of gene therapy for hemophilia. This series was a collaboration with the American Thrombosis & Hemostasis Network (ATHN) and partially supported by the National Hemophilia Foundation.

    Gene Therapy for Providers 101 provides basic education on hemophilia gene therapy, including the aims of gene therapy, the packaging, delivery, and activity of the replacement genes; and how the replacement genes lead to production and/or availability of normal clotting factor in persons with hemophilia. Gene Therapy for Providers 201 is a process-oriented intermediate activity that will guide HTC multidisciplinary staff and institutional stakeholders to gain knowledge on the steps necessary to prepare an institution to administer AAV-mediated gene therapy for hemophilia. Gene Therapy for Providers 301 is a process-oriented activity that will enable HTC multidisciplinary staff and hospital staff to support patients and their families as they consider hemophilia gene therapy, including education of patients and families on basic concepts in hemophilia gene therapy; administrative preparedness for providers; and short- and long-term care demands.

    These activities are intended for multidisciplinary providers at hemophilia treatment centers, including nurses, physicians, pharmacists, physical therapists, social workers, and genetic counselors providing care to persons with hemophilia A and hemophilia B.

    The activity provides continuing education credit for physicians, physician assistant, pharmacists, nurse practitioners, and nurses. Click on the Online Education tab above for the full accreditation information and participate in all 3 activities today!